{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T21:29:58Z","timestamp":1785533398835,"version":"3.56.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T00:00:00Z","timestamp":1697587200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T00:00:00Z","timestamp":1697587200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Immunosuppression is a significant factor contributing to the poor prognosis of cancer. <jats:italic>S100P<\/jats:italic>, a member of the S100 protein family, has been implicated in various cancers. However, its role in the tumor microenvironment (TME) of pancreatic cancer remains unclear. This study aimed to investigate the potential impact of <jats:italic>S100P<\/jats:italic> on TME characteristics in patients with pancreatic cancer.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Multiple data (including microarray, RNA-Seq, and scRNA-Seq) were obtained from public databases. The expression pattern of <jats:italic>S100P<\/jats:italic> was comprehensively evaluated in RNA-Seq data and validated in four different microarray datasets. Prognostic value was assessed through Kaplan-Meier plotter and Cox regression analyses. Immune infiltration levels were determined using the ESTIMATE and ssGSEA algorithms and validated at the single-cell level. <jats:italic>Spearman<\/jats:italic> correlation test was used to examine the correlation between <jats:italic>S100P<\/jats:italic> expression and immune checkpoint genes, and tumor mutation burden (TMB). DNA methylation analysis was performed to investigate the change in mRNA expression. Reverse transcription PCR (RT-PCR) and immunohistochemical (IHC) were utilized to validate the expression using five cell lines and 60 pancreatic cancer tissues.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>This study found that <jats:italic>S100P<\/jats:italic> was differentially expressed in pancreatic cancer and was associated with poor prognosis (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). Notably, <jats:italic>S100P<\/jats:italic> exhibited a significant negative-correlation with immune cell infiltration, particularly CD8\u2009+\u2009T cells. Furthermore, a close association between <jats:italic>S100P<\/jats:italic> and immunotherapy was observed, as it strongly correlated with TMB and the expression levels of <jats:italic>TIGIT<\/jats:italic>, <jats:italic>HAVCR2<\/jats:italic>, <jats:italic>CTLA4<\/jats:italic>, and <jats:italic>BTLA<\/jats:italic> (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). Intriguingly, higher <jats:italic>S100P<\/jats:italic> expression demonstrated a negative correlation with methylation levels (cg14323984, cg27027375, cg14900031, cg14140379, cg25083732, cg07210669, cg26233331, and cg22266967), which were associated with CD8\u2009+\u2009T cells. In vitro RT-PCR validated upregulated <jats:italic>S100P<\/jats:italic> expression across all five pancreatic cancer cell lines, and IHC confirmed high S100P levels in pancreatic cancer tissues (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>These findings suggest that <jats:italic>S100P<\/jats:italic> could serve as a promising biomarker for immunosuppressive microenvironment, which may provide a novel therapeutic way for pancreatic cancer.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-023-11490-1","type":"journal-article","created":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T14:02:35Z","timestamp":1697637755000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["S100P as a potential biomarker for immunosuppressive microenvironment in pancreatic cancer: a bioinformatics analysis and in vitro study"],"prefix":"10.1186","volume":"23","author":[{"given":"Weiwei","family":"Hao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwen","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pu","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jicun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,18]]},"reference":[{"key":"11490_CR1","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41575-021-00457-x","volume":"18","author":"AP Klein","year":"2021","unstructured":"Klein AP. Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors. Nat Rev Gastroenterol Hepatol. 2021;18:493\u2013502.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"11490_CR2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72:7\u201333.","journal-title":"CA Cancer J Clin"},{"key":"11490_CR3","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.ejca.2021.07.039","volume":"157","author":"T Dyba","year":"2021","unstructured":"Dyba T, Randi G, Bray F, Martos C, Giusti F, Nicholson N, et al. The European cancer burden in 2020: incidence and mortality estimates for 40 countries and 25 major cancers. Eur J Cancer. 2021;157:308\u201347.","journal-title":"Eur J Cancer"},{"key":"11490_CR4","first-page":"851","volume":"326","author":"W Park","year":"2021","unstructured":"Park W, Chawla A, O\u2019Reilly EM. Pancreat Cancer: Rev JAMA. 2021;326:851.","journal-title":"Pancreat Cancer: Rev JAMA"},{"key":"11490_CR5","doi-asserted-by":"crossref","first-page":"680407","DOI":"10.3389\/fimmu.2021.680407","volume":"12","author":"L Mao","year":"2021","unstructured":"Mao L, Qi Z, Zhang L, Guo J, Si L. Immunotherapy in Acral and Mucosal Melanoma: current status and future directions. Front Immunol. 2021;12:680407.","journal-title":"Front Immunol"},{"key":"11490_CR6","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1007\/s00262-020-02752-z","volume":"70","author":"EM Brozos-V\u00e1zquez","year":"2021","unstructured":"Brozos-V\u00e1zquez EM, D\u00edaz-Pe\u00f1a R, Garc\u00eda-Gonz\u00e1lez J, Le\u00f3n-Mateos L, Mondelo-Mac\u00eda P, Pe\u00f1a-Chilet M, et al. Immunotherapy in nonsmall-cell Lung cancer: current status and future prospects for liquid biopsy. Cancer Immunol Immunother. 2021;70:1177\u201388.","journal-title":"Cancer Immunol Immunother"},{"key":"11490_CR7","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1158\/2159-8290.CD-20-1209","volume":"11","author":"TA Yap","year":"2021","unstructured":"Yap TA, Parkes EE, Peng W, Moyers JT, Curran MA, Tawbi HA. Development of Immunotherapy combination strategies in Cancer. Cancer Discov. 2021;11:1368\u201397.","journal-title":"Cancer Discov"},{"key":"11490_CR8","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s40164-022-00277-y","volume":"11","author":"Q Jia","year":"2022","unstructured":"Jia Q, Wang A, Yuan Y, Zhu B, Long H. Heterogeneity of the Tumor immune microenvironment and its clinical relevance. Exp Hematol Oncol. 2022;11:24.","journal-title":"Exp Hematol Oncol"},{"key":"11490_CR9","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1186\/s12935-021-02085-6","volume":"21","author":"Y Luo","year":"2021","unstructured":"Luo Y, Yin S, Lu J, Zhou S, Shao Y, Bao X, et al. Tumor microenvironment: a prospective target of natural alkaloids for cancer treatment. Cancer Cell Int. 2021;21:386.","journal-title":"Cancer Cell Int"},{"key":"11490_CR10","doi-asserted-by":"crossref","first-page":"4401","DOI":"10.1038\/s41467-019-12319-x","volume":"10","author":"E Menares","year":"2019","unstructured":"Menares E, G\u00e1lvez-Cancino F, C\u00e1ceres-Morgado P, Ghorani E, L\u00f3pez E, D\u00edaz X, et al. Tissue-resident memory CD8 + T cells amplify anti-tumor immunity by triggering antigen spreading through dendritic cells. Nat Commun. 2019;10:4401.","journal-title":"Nat Commun"},{"key":"11490_CR11","doi-asserted-by":"crossref","unstructured":"Liu X, Wang W, Liu X, Zhang Z, Yu L, Li R et al. Multi-omics analysis of intra\u2010tumoural and inter\u2010tumoural heterogeneity in pancreatic ductal adenocarcinoma. Clin Transl Med. 2022;12.","DOI":"10.1002\/ctm2.670"},{"key":"11490_CR12","doi-asserted-by":"crossref","first-page":"566302","DOI":"10.3389\/fonc.2020.566302","volume":"10","author":"Y Cong","year":"2020","unstructured":"Cong Y, Cui Y, Wang S, Jiang L, Cao J, Zhu S, et al. Calcium-binding protein S100P promotes Tumor Progression but enhances chemosensitivity in Breast Cancer. Front Oncol. 2020;10:566302.","journal-title":"Front Oncol"},{"key":"11490_CR13","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s12964-019-0465-9","volume":"17","author":"P Carneiro","year":"2019","unstructured":"Carneiro P, Moreira AM, Figueiredo J, Barros R, Oliveira P, Fernandes MS, et al. S100P is a molecular determinant of E-cadherin function in gastric cancer. Cell Commun Signal. 2019;17:155.","journal-title":"Cell Commun Signal"},{"key":"11490_CR14","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2019.4812","author":"H Nakayama","year":"2019","unstructured":"Nakayama H, Ohuchida K, Yonenaga A, Sagara A, Ando Y, Kibe S, et al. S100P regulates the collective invasion of Pancreatic cancer cells into the lymphatic endothelial monolayer. Int J Oncol. 2019. https:\/\/doi.org\/10.3892\/ijo.2019.4812.","journal-title":"Int J Oncol"},{"key":"11490_CR15","doi-asserted-by":"crossref","first-page":"649551","DOI":"10.3389\/fimmu.2021.649551","volume":"12","author":"H Ye","year":"2021","unstructured":"Ye H, Li T, Wang H, Wu J, Yi C, Shi J, et al. TSPAN1, TMPRSS4, SDR16C5, and CTSE as Novel Panel for Pancreatic Cancer: a Bioinformatics analysis and experiments validation. Front Immunol. 2021;12:649551.","journal-title":"Front Immunol"},{"key":"11490_CR16","doi-asserted-by":"crossref","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z Tang","year":"2017","unstructured":"Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45:W98\u2013102.","journal-title":"Nucleic Acids Res"},{"key":"11490_CR17","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara K, Shahmoradgoli M, Mart\u00ednez E, Vegesna R, Kim H, Torres-Garcia W, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4:2612.","journal-title":"Nat Commun"},{"key":"11490_CR18","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","volume":"48","author":"V Thorsson","year":"2018","unstructured":"Thorsson V, Gibbs DL, Brown SD, Wolf D, Bortone DS, Ou Yang T-H, et al. The Immune Landscape of Cancer. Immunity. 2018;48:812\u2013830e14.","journal-title":"Immunity"},{"key":"11490_CR19","doi-asserted-by":"crossref","first-page":"D1420","DOI":"10.1093\/nar\/gkaa1020","volume":"49","author":"D Sun","year":"2021","unstructured":"Sun D, Wang J, Han Y, Dong X, Ge J, Zheng R, et al. TISCH: a comprehensive web resource enabling interactive single-cell transcriptome visualization of Tumor microenvironment. Nucleic Acids Res. 2021;49:D1420\u201330.","journal-title":"Nucleic Acids Res"},{"key":"11490_CR20","doi-asserted-by":"crossref","first-page":"D870","DOI":"10.1093\/nar\/gkac947","volume":"51","author":"C Hu","year":"2023","unstructured":"Hu C, Li T, Xu Y, Zhang X, Li F, Bai J, et al. CellMarker 2.0: an updated database of manually curated cell markers in human\/mouse and web tools based on scRNA-seq data. Nucleic Acids Res. 2023;51:D870\u20136.","journal-title":"Nucleic Acids Res"},{"key":"11490_CR21","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1101\/gr.239244.118","volume":"28","author":"A Mayakonda","year":"2018","unstructured":"Mayakonda A, Lin D-C, Assenov Y, Plass C, Koeffler HP. Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res. 2018;28:1747\u201356.","journal-title":"Genome Res"},{"key":"11490_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40364-017-0081-z","volume":"5","author":"W Zhang","year":"2017","unstructured":"Zhang W, Xu J. DNA methyltransferases and their roles in tumorigenesis. Biomark Res. 2017;5:1.","journal-title":"Biomark Res"},{"key":"11490_CR23","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neo.2022.01.001","volume":"25","author":"DS Chandrashekar","year":"2022","unstructured":"Chandrashekar DS, Karthikeyan SK, Korla PK, Patel H, Shovon AR, Athar M, et al. UALCAN: an update to the integrated cancer data analysis platform. Neoplasia. 2022;25:18\u201327.","journal-title":"Neoplasia"},{"key":"11490_CR24","doi-asserted-by":"crossref","first-page":"5356","DOI":"10.1158\/1078-0432.CCR-05-0092","volume":"11","author":"T Arumugam","year":"2005","unstructured":"Arumugam T, Simeone DM, Van Golen K, Logsdon CD. S100P promotes Pancreatic Cancer Growth, Survival, and Invasion. Clin Cancer Res. 2005;11:5356\u201364.","journal-title":"Clin Cancer Res"},{"key":"11490_CR25","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nrc3893","volume":"15","author":"AR Bresnick","year":"2015","unstructured":"Bresnick AR, Weber DJ, Zimmer DB. S100 proteins in cancer. Nat Rev Cancer. 2015;15:96\u2013109.","journal-title":"Nat Rev Cancer"},{"key":"11490_CR26","doi-asserted-by":"crossref","first-page":"22508","DOI":"10.18632\/oncotarget.7999","volume":"7","author":"A Gibadulinova","year":"2016","unstructured":"Gibadulinova A, Pastorek M, Filipcik P, Radvak P, Csaderova L, Vojtesek B, et al. Cancer-associated S100P protein binds and inactivates p53, permits therapy-induced senescence and supports chemoresistance. Oncotarget. 2016;7:22508\u201322.","journal-title":"Oncotarget"},{"key":"11490_CR27","doi-asserted-by":"crossref","first-page":"9006","DOI":"10.1080\/21655979.2021.1992331","volume":"12","author":"W Zou","year":"2021","unstructured":"Zou W, Li L, Wang Z, Jiang N, Wang F, Hu M, et al. Up-regulation of S100P predicts the poor long-term survival and construction of prognostic signature for survival and immunotherapy in patients with Pancreatic cancer. Bioengineered. 2021;12:9006\u201320.","journal-title":"Bioengineered"},{"key":"11490_CR28","doi-asserted-by":"crossref","first-page":"758004","DOI":"10.3389\/fimmu.2021.758004","volume":"12","author":"Y Chen","year":"2021","unstructured":"Chen Y, Wang C, Song J, Xu R, Ruze R, Zhao Y. S100A2 is a prognostic biomarker involved in Immune Infiltration and Predict Immunotherapy Response in Pancreatic Cancer. Front Immunol. 2021;12:758004.","journal-title":"Front Immunol"},{"key":"11490_CR29","first-page":"e2300110","volume":"10","author":"H Li","year":"2023","unstructured":"Li H, Chen J, Li Z, Chen M, Ou Z, Mo M, et al. S100A5 attenuates efficiency of Anti-PD-L1\/PD-1 immunotherapy by inhibiting CD8 + T cell-mediated anti-cancer immunity in bladder carcinoma. Adv Sci Weinh Baden-Wurtt Ger. 2023;10:e2300110.","journal-title":"Adv Sci Weinh Baden-Wurtt Ger"},{"key":"11490_CR30","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1186\/s12885-022-09927-0","volume":"22","author":"C Wang","year":"2022","unstructured":"Wang C, Chen Y, Xinpeng Y, Xu R, Song J, Ruze R, et al. Construction of immune-related signature and identification of S100A14 determining immune-suppressive microenvironment in Pancreatic cancer. BMC Cancer. 2022;22:879.","journal-title":"BMC Cancer"},{"key":"11490_CR31","doi-asserted-by":"crossref","first-page":"112621","DOI":"10.1016\/j.ejmech.2020.112621","volume":"203","author":"R Camara","year":"2020","unstructured":"Camara R, Ogbeni D, Gerstmann L, Ostovar M, Hurer E, Scott M, et al. Discovery of novel small molecule inhibitors of S100P with in vitro anti-metastatic effects on Pancreatic cancer cells. Eur J Med Chem. 2020;203:112621.","journal-title":"Eur J Med Chem"},{"key":"11490_CR32","doi-asserted-by":"crossref","first-page":"eadd8977","DOI":"10.1126\/sciadv.add8977","volume":"9","author":"C Liu","year":"2023","unstructured":"Liu C, Zhang M, Yan X, Ni Y, Gong Y, Wang C, et al. Single-cell dissection of cellular and molecular features underlying human cervical squamous cell carcinoma initiation and progression. Sci Adv. 2023;9:eadd8977.","journal-title":"Sci Adv"},{"key":"11490_CR33","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10620-020-06183-9","volume":"66","author":"J Wu","year":"2021","unstructured":"Wu J, Cai J. Dilemma and challenge of Immunotherapy for Pancreatic Cancer. Dig Dis Sci. 2021;66:359\u201368.","journal-title":"Dig Dis Sci"},{"key":"11490_CR34","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.2147\/OTT.S278089","volume":"14","author":"DB Sacdalan","year":"2021","unstructured":"Sacdalan DB, Lucero JA. The Association between Inflammation and immunosuppression: implications for ICI Biomarker Development. OncoTargets Ther. 2021;14:2053\u201364.","journal-title":"OncoTargets Ther"},{"key":"11490_CR35","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s40364-022-00391-3","volume":"10","author":"J Wu","year":"2022","unstructured":"Wu J, Wang L, Xu J. The role of pyroptosis in modulating the Tumor immune microenvironment. Biomark Res. 2022;10:45.","journal-title":"Biomark Res"},{"key":"11490_CR36","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/s41568-020-0285-7","volume":"20","author":"D Bruni","year":"2020","unstructured":"Bruni D, Angell HK, Galon J. The immune contexture and immunoscore in cancer prognosis and therapeutic efficacy. Nat Rev Cancer. 2020;20:662\u201380.","journal-title":"Nat Rev Cancer"},{"key":"11490_CR37","doi-asserted-by":"crossref","first-page":"6047","DOI":"10.1002\/jmv.28084","volume":"94","author":"X Li","year":"2022","unstructured":"Li X, Zhang M, Lei T, Zou W, Huang R, Wang F, et al. Single-cell RNA-sequencing dissects cellular heterogeneity and identifies two tumor-suppressing immune cell subclusters in HPV-related cervical adenosquamous carcinoma. J Med Virol. 2022;94:6047\u201359.","journal-title":"J Med Virol"},{"key":"11490_CR38","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40364-022-00369-1","volume":"10","author":"K-Y Jiang","year":"2022","unstructured":"Jiang K-Y, Qi L-L, Kang F-B, Wang L. The intriguing roles of Siglec family members in the Tumor microenvironment. Biomark Res. 2022;10:22.","journal-title":"Biomark Res"},{"key":"11490_CR39","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/annonc\/mdy495","volume":"30","author":"TA Chan","year":"2019","unstructured":"Chan TA, Yarchoan M, Jaffee E, Swanton C, Quezada SA, Stenzinger A, et al. Development of Tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic. Ann Oncol. 2019;30:44\u201356.","journal-title":"Ann Oncol"},{"key":"11490_CR40","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.cell.2010.08.040","volume":"143","author":"M Feng","year":"2010","unstructured":"Feng M, Grice DM, Faddy HM, Nguyen N, Leitch S, Wang Y, et al. Store-Independent activation of Orai1 by SPCA2 in mammary tumors. Cell. 2010;143:84\u201398.","journal-title":"Cell"},{"key":"11490_CR41","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.molcel.2018.08.014","volume":"72","author":"L Sang","year":"2018","unstructured":"Sang L, Ju H, Liu G, Tian T, Ma G, Lu Y, et al. LncRNA CamK-A regulates Ca2+-Signaling-mediated Tumor Microenvironment Remodeling. Mol Cell. 2018;72:71\u201383e7.","journal-title":"Mol Cell"},{"key":"11490_CR42","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1002\/eji.1830200913","volume":"20","author":"T Schlunck","year":"1990","unstructured":"Schlunck T, Schraut W, Riethm\u00fcller G, Ziegler-Heitbrock HWL. Inverse relationship of CA2 + mobilization and cell proliferation in CD8 + memory and virgin T cells. Eur J Immunol. 1990;20:1957\u201363.","journal-title":"Eur J Immunol"},{"key":"11490_CR43","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1021\/acsnano.1c07893","volume":"16","author":"B Liu","year":"2022","unstructured":"Liu B, Bian Y, Liang S, Yuan M, Dong S, He F, et al. One-step integration of Tumor Microenvironment-Responsive Calcium and Copper Peroxides Nanocomposite for enhanced Chemodynamic\/Ion-Interference therapy. ACS Nano. 2022;16:617\u201330.","journal-title":"ACS Nano"},{"key":"11490_CR44","doi-asserted-by":"crossref","first-page":"14051","DOI":"10.1002\/anie.202102703","volume":"60","author":"X Tan","year":"2021","unstructured":"Tan X, Huang J, Wang Y, He S, Jia L, Zhu Y, et al. Transformable nanosensitizer with Tumor Microenvironment-activated sonodynamic process and calcium release for enhanced Cancer Immunotherapy. Angew Chem Int Ed. 2021;60:14051\u20139.","journal-title":"Angew Chem Int Ed"},{"key":"11490_CR45","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.7150\/ijbs.70137","volume":"18","author":"D Rong","year":"2022","unstructured":"Rong D, Sun G, Zheng Z, Liu L, Chen X, Wu F, et al. MGP promotes CD8 + T cell exhaustion by activating the NF-\u03baB pathway leading to liver Metastasis of Colorectal cancer. Int J Biol Sci. 2022;18:2345\u201361.","journal-title":"Int J Biol Sci"},{"key":"11490_CR46","doi-asserted-by":"crossref","first-page":"e92","DOI":"10.1038\/oncsis.2014.7","volume":"3","author":"S Dakhel","year":"2014","unstructured":"Dakhel S, Padilla L, Adan J, Masa M, Martinez JM, Roque L, et al. S100P antibody-mediated therapy as a new promising strategy for the treatment of Pancreatic cancer. Oncogenesis. 2014;3:e92.","journal-title":"Oncogenesis"},{"key":"11490_CR47","doi-asserted-by":"crossref","first-page":"12000","DOI":"10.3390\/ijms231912000","volume":"23","author":"AS Kazakov","year":"2022","unstructured":"Kazakov AS, Deryusheva EI, Permyakova ME, Sokolov AS, Rastrygina VA, Uversky VN, et al. Calcium-bound S100P protein is a promiscuous binding Partner of the four-helical cytokines. Int J Mol Sci. 2022;23:12000.","journal-title":"Int J Mol Sci"},{"key":"11490_CR48","doi-asserted-by":"crossref","first-page":"e24382","DOI":"10.1002\/jcla.24382","volume":"36","author":"Z Lin","year":"2022","unstructured":"Lin Z, Yu B, Yuan L, Tu J, Shao C, Tang Y. RAGE is a potential biomarker implicated in immune infiltrates and cellular senescence in lung adenocarcinoma. J Clin Lab Anal. 2022;36:e24382.","journal-title":"J Clin Lab Anal"},{"key":"11490_CR49","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13046-021-02221-0","volume":"41","author":"S Mishra","year":"2022","unstructured":"Mishra S, Charan M, Shukla RK, Agarwal P, Misri S, Verma AK, et al. cPLA2 blockade attenuates S100A7-mediated breast tumorigenicity by inhibiting the immunosuppressive Tumor microenvironment. J Exp Clin Cancer Res CR. 2022;41:54.","journal-title":"J Exp Clin Cancer Res CR"},{"key":"11490_CR50","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1158\/1535-7163.MCT-12-0771","volume":"12","author":"T Arumugam","year":"2013","unstructured":"Arumugam T, Ramachandran V, Sun D, Peng Z, Pal A, Maxwell DS, et al. Designing and developing S100P inhibitor 5-methyl cromolyn for Pancreatic cancer therapy. Mol Cancer Ther. 2013;12:654\u201362.","journal-title":"Mol Cancer Ther"},{"key":"11490_CR51","doi-asserted-by":"crossref","first-page":"4356","DOI":"10.1158\/1078-0432.CCR-12-0221","volume":"18","author":"T Arumugam","year":"2012","unstructured":"Arumugam T, Ramachandran V, Gomez SB, Schmidt AM, Logsdon CD. S100P-derived RAGE antagonistic peptide reduces Tumor growth and Metastasis. Clin Cancer Res off J Am Assoc Cancer Res. 2012;18:4356\u201364.","journal-title":"Clin Cancer Res off J Am Assoc Cancer Res"},{"key":"11490_CR52","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1038\/sj.onc.1207269","volume":"23","author":"N Sato","year":"2004","unstructured":"Sato N, Fukushima N, Matsubayashi H, Goggins M. Identification of maspin and S100P as novel hypomethylation targets in Pancreatic cancer using global gene expression profiling. Oncogene. 2004;23:1531\u20138.","journal-title":"Oncogene"},{"key":"11490_CR53","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.trecan.2020.02.003","volume":"6","author":"J Cao","year":"2020","unstructured":"Cao J, Yan Q. Cancer epigenetics, Tumor Immunity, and Immunotherapy. Trends Cancer. 2020;6:580\u201392.","journal-title":"Trends Cancer"},{"key":"11490_CR54","doi-asserted-by":"crossref","unstructured":"Yi M, Dong B, Chu Q, Wu K. Immune pressures drive the promoter hypermethylation of neoantigen genes. Exp Hematol Oncol. 2019;8:32, s40164-019-0156\u20137.","DOI":"10.1186\/s40164-019-0156-7"},{"key":"11490_CR55","doi-asserted-by":"crossref","first-page":"e000552","DOI":"10.1136\/jitc-2020-000552","volume":"8","author":"N Kl\u00fcmper","year":"2020","unstructured":"Kl\u00fcmper N, Ralser DJ, Bawden EG, Landsberg J, Zarbl R, Kristiansen G, et al. LAG3 (LAG-3, CD223) DNA methylation correlates with LAG3 expression by Tumor and immune cells, immune cell infiltration, and overall survival in clear cell renal cell carcinoma. J Immunother Cancer. 2020;8:e000552.","journal-title":"J Immunother Cancer"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-023-11490-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-023-11490-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-023-11490-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T21:15:16Z","timestamp":1700514916000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-023-11490-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,18]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["11490"],"URL":"https:\/\/doi.org\/10.1186\/s12885-023-11490-1","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,18]]},"assertion":[{"value":"27 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted by the Institutional Review Board of the First Affiliated Hospital of Zhengzhou University. Informed consent was obtained from all individuals or individuals\u2019 guardians.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"997"}}